← All stocks

Unicycive Therapeutics, Inc.

UNCY Net buying
CIK 0001766140 #4114 in the set updated 22 Sep 2026
Bought (120 mo)
$12.38K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
+$12.38K
+$12.38K against sales at will

By person

5 insiders · 1 transaction
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Schiller Brigitte
Director
$12.38K (1)
+$12.38K
26,738
$22.06K
Gupta Shalabh K.
CEO
2,527,449
$2.09M
+4.3%
Aggarwal Gaurav
Director
1,789,915
$1.48M
Jermasek Douglas
EVP, Corporate Strategy
175,012
$144.38K
+148.6%
Gupta Pramod
EVP, Pharmaceuticals and BD
41,845
$34.52K

No percentages here. This company's share count has moved by a factor of 6.8 over the window, from 17,661,698 to 119,705,026 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Schiller Brigitte
16 May 2022
Director
Buy
15,000
$0.83
$12.38K

What was left out

Form 4 filings counted 49
Amendments (4/A) skipped 9
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 11,300,859
History held since 26 Jul 2021